Company attributes
Venture Capital Firm attributes
Other attributes
Nextech Invest Ltd is a private equity and venture capital firm in Switzerland that focuses on precision therapies in oncology. Founded 1998 in Zurich, Switzerland, it invests in early stage ventures, series B, series C, post-IPO equity, and series E rounds. Its portfolio companies include Circle Pharma, Silverback Therapeutics, Kinnate Biopharma, PMV Pharmaceuticals, and A2 Biotherapeutics. As of April 2020, Nextech Invest has made 33 investments. Their most recent investment was on March 17, 2020, when Circle Pharma raised $45M. Nextech Invest has had 17 exits, the most notable of which include Arvinas, Blueprint Medicines, and IDEAYA Biosciences. The company has raised a single venture fund, Oncology Fund IV. This fund was announced on July 21, 2016 and raised a total of $64M.
